ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

VP, U.S. Medical Affairs at Dyne Therapeutics - ApplyBlast

VP, U.S. Medical Affairs

Dyne Therapeutics

5 months ago

4.1 on Glassdoor

Waltham, MA

Onsite

Full Time

Executive

1 applicant

View Job Listing

Apply to 100+ jobs

About this role

The VP, U.S. Medical Affairs at Dyne Therapeutics serves as the senior U.S. medical leader with end-to-end accountability for the launch and early commercialization of the company's first approved product for genetically driven neuromuscular diseases. This executive role defines and executes the U.S. medical strategy, builds a high-performing Medical Affairs organization, and acts as a trusted strategic advisor to leadership while driving engagement with key external stakeholders like payers, KOLs, and patient communities.

Responsibilities

Define and execute the U.S. medical strategy and launch plan
Build and scale a high-performing U.S. Medical Affairs organization
Establish scientific credibility with key opinion leaders and payers
Oversee evidence generation and product lifecycle management
Ensure medical governance, compliance, and ethical conduct standards

Skills

Qualifications

MD DegreePhD DegreePharmD Degree

About Dyne Therapeutics

dyne-tx.com

Headquarters

Waltham, Massachusetts, United States

Company Size

51-200 employees

Founded

2018

View Profile

Dyne Therapeutics is a biotechnology company developing nucleic acid–based therapies for genetically driven neuromuscular diseases. Leveraging its proprietary FORCE™ platform, Dyne aims to address the root cause of disease and deliver functional improvement for people living with conditions such as Duchenne muscular dystrophy (DMD), myotonic dystrophy type 1 (DM1), and facioscapulohumeral muscular dystrophy (FSHD). The company advances a pipeline of therapeutics from discovery through clinical development with the mission of transforming the lives of patients with rare neuromuscular diseases.